Alabama will receive about $250 million in an opioid settlement with drugmakers and pharmacies announced last week.

Last week, Alabama Attorney General Steve Marshall said that $17.3 billion in opioid agreements with drug makers Teva and Allergan and pharmacies CVS and Walgreens had been approved. 

Alabama will receive $248,948,247 from the settlement.

The defendants have committed to the deal and will begin releasing funds to a national administrator later this summer. According to Marshall, money is expected to start flowing to state and local governments by the end of 2023.

"The opioid crisis is a blight on our society and has had costly effects on our communities," Marshall said in a statement. "My office will never stop holding those responsible companies accountable for the irreparable harm to our state."

The settlements will also require Teva's opioid business to provide stringent injunctive relief that, among other things, will prevent all opioid marketing and ensure systems are in place to prevent drug misuse. 

Additionally, Allergan is required to stop selling opioids for the next 10 years. CVS and Walgreens have agreed to injunctive relief that requires the pharmacies to monitor, report and share data about suspicious activity related to opioid prescriptions. 

Teva and Allergan negotiations were led by attorneys general from North Carolina, Iowa, California, Illinois, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas, Vermont, Virginia and Wisconsin. 

CVS and Walgreens negotiations were led by Attorneys General from North Carolina, California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Kentucky, Louisiana, Massachusetts, Nebraska, New York, Ohio, Pennsylvania, Rhode Island, Tennessee and Texas.

To connect with the author of this story or to comment, email

Don't miss out! Subscribe to our newsletter and get our top stories every weekday morning.